Clinical trials
Completed Gliosarcoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
303 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 18 |
| 2001 | 19 |
| 2002 | 20 |
| 2003 | 9 |
| 2004 | 13 |
| 2005 | 24 |
| 2006 | 23 |
| 2007 | 25 |
| 2008 | 18 |
| 2009 | 18 |
| 2010 | 15 |
| 2011 | 7 |
| 2012 | 8 |
| 2013 | 8 |
| 2014 | 4 |
| 2015 | 8 |
| 2016 | 6 |
| 2017 | 6 |
| 2018 | 2 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 303 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 70 |
| Duke University | 34 |
| Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 23 |
| Jonsson Comprehensive Cancer Center | 11 |
| Memorial Sloan Kettering Cancer Center | 9 |
| Radiation Therapy Oncology Group | 9 |
| City of Hope Medical Center | 8 |
| New Approaches to Brain Tumor Therapy Consortium | 8 |
| Alliance for Clinical Trials in Oncology | 7 |
| Case Comprehensive Cancer Center | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gliosarcoma | 303 |
| Glioblastoma | 300 |
| Brain Neoplasms | 192 |
| Astrocytoma | 152 |
| Central Nervous System Neoplasms | 150 |
| Glioma | 130 |
| Oligodendroglioma | 116 |
| Ependymoma | 48 |
| Medulloblastoma | 29 |
| Glioma, Subependymal | 28 |
Trials
Showing 1 to 25 of 303. Each trial links to its page on Pharma Observatory.
203 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.